FABP1 and metabolic dysfunction-associated steatotic liver disease: And these decreased expressions of the target genes resulted in impaired fatty acid transport (DBI and FABP1) and oxidation (CYP4A1), which contributed to fatty acid accumulation in the NAFLD liver.